As of 2025-06-16, the Relative Valuation of Neoleukin Therapeutics Inc (NLTX) is (57.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.49 USD, the upside of Neoleukin Therapeutics Inc based on Relative Valuation is -1761.0%.
The range of the Relative Valuation is (42.87) - (73.21) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.2x - 20.1x | 15.6x |
| Forward P/E multiples | 11.8x - 22.7x | 16.2x |
| Fair Price | (42.87) - (73.21) | (57.97) |
| Upside | -1328.5% - -2197.6% | -1761.0% |
| Date | P/E |